{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:28:03Z","timestamp":1787153283790,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-02992-5","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:45:12Z","timestamp":1781333112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond traditional risk factors: the impact of cumulative inflammation and remnant cholesterol on myocardial infarction in a prospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Kanghao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"25","key":"2992_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"2992_CR2","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/eurheartj\/ehac822","volume":"44","author":"BN Wadstr\u00f6m","year":"2023","unstructured":"Wadstr\u00f6m BN, Pedersen KM, Wulff AB, Nordestgaard BG. Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality. Eur Heart J. 2023;44(16):1432\u201345.","journal-title":"Eur Heart J"},{"issue":"3","key":"2992_CR3","doi-asserted-by":"publisher","first-page":"e013600","DOI":"10.1161\/JAHA.119.013600","volume":"9","author":"R Quispe","year":"2020","unstructured":"Quispe R, Michos ED, Martin SS, Puri R, Toth PP, Al Suwaidi J, et al. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study. J Am Heart Assoc. 2020;9(3):e013600.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2992_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jamacardio.2023.5605","volume":"9","author":"AM Small","year":"2024","unstructured":"Small AM, Pournamdari A, Melloni GEM, Scirica BM, Bhatt DL, Raz I, et al. Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations. JAMA Cardiol. 2024;9(4):385\u201391.","journal-title":"JAMA Cardiol"},{"issue":"42","key":"2992_CR5","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1093\/eurheartj\/ehab432","volume":"42","author":"R Quispe","year":"2021","unstructured":"Quispe R, Martin SS, Michos ED, Lamba I, Blumenthal RS, Saeed A, et al. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. Eur Heart J. 2021;42(42):4324\u201332.","journal-title":"Eur Heart J"},{"issue":"16","key":"2992_CR6","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/eurheartj\/ehac783","volume":"44","author":"PE St\u00fcrzebecher","year":"2023","unstructured":"St\u00fcrzebecher PE, Katzmann JL, Laufs U. What is \u2018remnant cholesterol\u2019? Eur Heart J. 2023;44(16):1446\u20138.","journal-title":"Eur Heart J"},{"issue":"1","key":"2992_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.amjcard.2011.08.010","volume":"109","author":"J Hermida","year":"2012","unstructured":"Hermida J, Lopez FL, Montes R, Matsushita K, Astor BC, Alonso A. Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol. 2012;109(1):95\u20139.","journal-title":"Am J Cardiol"},{"issue":"9709","key":"2992_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","volume":"375","author":"S Kaptoge","year":"2010","unstructured":"Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132\u201340.","journal-title":"Lancet"},{"issue":"17","key":"2992_CR9","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","volume":"72","author":"P Libby","year":"2018","unstructured":"Libby P, Loscalzo J, Ridker PM, Farkouh ME, Hsue PY, Fuster V, et al. Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. J Am Coll Cardiol. 2018;72(17):2071\u201381.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2992_CR10","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822\u201332.","journal-title":"Nat Med"},{"key":"2992_CR11","doi-asserted-by":"publisher","unstructured":"Zhao XM, Wang YF, Li W, Gao HB, Wu HT, Yu JX et al. Cumulative remnant cholesterol as a causal risk factor for ischemic heart disease: a prospective cohort study. Curr Prob Cardiol. 2024;49(2):102215. https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102215.","DOI":"10.1016\/j.cpcardiol.2023.102215"},{"key":"2992_CR12","doi-asserted-by":"publisher","unstructured":"Wang A, Liu J, Li C, Gao J, Li X, Chen S et al. Cumulative exposure to high-sensitivity C-reactive protein predicts the risk of cardiovascular disease. J Am Heart Assoc. 2017;6(10):e005610. https:\/\/doi.org\/10.1161\/JAHA.117.005610.","DOI":"10.1161\/JAHA.117.005610"},{"issue":"12","key":"2992_CR13","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1161\/CIRCRESAHA.120.317950","volume":"127","author":"M Zheng","year":"2020","unstructured":"Zheng M, Zhang X, Chen S, Song Y, Zhao Q, Gao X, et al. Arterial Stiffness Preceding Diabetes: A Longitudinal Study. Circ Res. 2020;127(12):1491\u20138.","journal-title":"Circ Res"},{"issue":"23","key":"2992_CR14","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.jacc.2020.04.038","volume":"75","author":"C Wang","year":"2020","unstructured":"Wang C, Yuan Y, Zheng M, Pan A, Wang M, Zhao M, et al. Association of Age of Onset of Hypertension With Cardiovascular Diseases and Mortality. J Am Coll Cardiol. 2020;75(23):2921\u201330.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2992_CR15","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1161\/HYPERTENSIONAHA.120.14833","volume":"76","author":"K Teramoto","year":"2020","unstructured":"Teramoto K, Nadruz Junior W, Matsushita K, Claggett B, John JE, Skali H, et al. Mid- to Late-Life Time-Averaged Cumulative Blood Pressure and Late-Life Cardiac Structure, Function, and Heart Failure. Hypertension. 2020;76(3):808\u201318.","journal-title":"Hypertension"},{"issue":"3","key":"2992_CR16","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/art.41122","volume":"72","author":"GA Karpouzas","year":"2020","unstructured":"Karpouzas GA, Ormseth SR, Hernandez E, Budoff MJ. Impact of Cumulative Inflammation, Cardiac Risk Factors, and Medication Exposure on Coronary Atherosclerosis Progression in Rheumatoid Arthritis. Arthritis Rheumatol. 2020;72(3):400\u20138.","journal-title":"Arthritis Rheumatol"},{"issue":"47","key":"2992_CR17","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1093\/eurheartj\/ehab293","volume":"42","author":"A Varbo","year":"2021","unstructured":"Varbo A, Nordestgaard BG. Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction. Eur Heart J. 2021;42(47):4833\u201343.","journal-title":"Eur Heart J"},{"issue":"1","key":"2992_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12916-023-02733-w","volume":"21","author":"Z Wu","year":"2023","unstructured":"Wu Z, Wang J, Zhang H, Pan H, Li Z, Liu Y, et al. Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol. BMC Med. 2023;21(1):42.","journal-title":"BMC Med"},{"issue":"1","key":"2992_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.atherosclerosis.2012.07.017","volume":"224","author":"EM DeGoma","year":"2012","unstructured":"DeGoma EM, French B, Dunbar RL, Allison MA, Mohler ER 3rd, Budoff MJ. Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2012;224(1):274\u20139.","journal-title":"Atherosclerosis"},{"issue":"6","key":"2992_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jacc.2015.11.037","volume":"67","author":"PM Ridker","year":"2016","unstructured":"Ridker PM. A Test in Context: High-Sensitivity C-Reactive Protein. J Am Coll Cardiol. 2016;67(6):712\u201323.","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"2992_CR21","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","volume":"76","author":"O Casta\u00f1er","year":"2020","unstructured":"Casta\u00f1er O, Pint\u00f3 X, Subirana I, Amor AJ, Ros E, Hern\u00e1ez \u00c1, et al. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease. J Am Coll Cardiol. 2020;76(23):2712\u201324.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"2992_CR22","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.jacc.2025.09.015","volume":"86","author":"HN Jung","year":"2025","unstructured":"Jung HN, Heo JH, Kim MJ, Han KD, Kang JG, Lee SJ. Remnant Cholesterol as an Independent Cardiovascular Risk Factor in Young Adults: An Age-Stratified Cohort Study. J Am Coll Cardiol. 2025;86(21):2047\u201358.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2992_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/clinchem\/hvae222","volume":"71","author":"BN Wadstr\u00f6m","year":"2025","unstructured":"Wadstr\u00f6m BN, Wulff AB, Pedersen KM, Nordestgaard BG. Small Remnants versus Large Triglyceride-Rich Lipoproteins in Risk of Atherosclerotic Cardiovascular Disease. Clin Chem. 2025;71(4):463\u201373.","journal-title":"Clin Chem"},{"key":"2992_CR24","doi-asserted-by":"publisher","unstructured":"Baratta F, Cocomello N, Coronati M, Ferro D, Pastori D, Angelico F et al. Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk. Int J Mol Sci. 2023;24(5):4268. https:\/\/doi.org\/10.3390\/ijms24054268.","DOI":"10.3390\/ijms24054268"},{"issue":"4","key":"2992_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","volume":"61","author":"A Varbo","year":"2013","unstructured":"Varbo A, Benn M, Tybj\u00e6rg-Hansen A, J\u00f8rgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61(4):427\u201336.","journal-title":"J Am Coll Cardiol"},{"key":"2992_CR26","doi-asserted-by":"publisher","unstructured":"Joshi PH, Khokhar AA, Massaro JM, Lirette ST, Griswold ME, Martin SS et al. Remnant lipoprotein cholesterol and incident coronary heart disease: the jackson heart and framingham offspring cohort studies. J Am Heart Assoc. 2016;5(5):e002765. https:\/\/doi.org\/10.1161\/JAHA.115.002765.","DOI":"10.1161\/JAHA.115.002765"},{"issue":"24","key":"2992_CR27","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/eurheartj\/ehs431","volume":"34","author":"AB J\u00f8rgensen","year":"2013","unstructured":"J\u00f8rgensen AB, Frikke-Schmidt R, West AS, Grande P, Nordestgaard BG, Tybj\u00e6rg-Hansen A. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. Eur Heart J. 2013;34(24):1826\u201333.","journal-title":"Eur Heart J"},{"issue":"12","key":"2992_CR28","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","volume":"128","author":"A Varbo","year":"2013","unstructured":"Varbo A, Benn M, Tybj\u00e6rg-Hansen A, Nordestgaard BG. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation. 2013;128(12):1298\u2013309.","journal-title":"Circulation"},{"key":"2992_CR29","doi-asserted-by":"publisher","unstructured":"Kraaijenhof JM, Kerkvliet MJ, Nurmohamed NS, Grefhorst A, Kroon J, Wareham NJ et al. The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk study. Eur J Prev Cardiol. 2026;33(5):729\u201339. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf037.","DOI":"10.1093\/eurjpc\/zwaf037"},{"key":"2992_CR30","doi-asserted-by":"publisher","first-page":"118532","DOI":"10.1016\/j.atherosclerosis.2024.118532","volume":"396","author":"JM Kraaijenhof","year":"2024","unstructured":"Kraaijenhof JM, Mol BM, Nurmohamed NS, Dzobo KE, Kroon J, Hovingh GK, et al. Plasma C-reactive protein is associated with a pro-inflammatory and adverse plaque phenotype. Atherosclerosis. 2024;396:118532.","journal-title":"Atherosclerosis"},{"key":"2992_CR31","doi-asserted-by":"publisher","unstructured":"Di Muro FM, Vogel B, Sartori S, Bay B, Oliva A, Feng Y et al. Prognostic impact of residual inflammatory and triglyceride risk in statin-treated patients with well-controlled LDL cholesterol and atherosclerotic cardiovascular disease. Eur J Prev Cardiol. 2026;33(5):742\u2013751. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf112.","DOI":"10.1093\/eurjpc\/zwaf112"},{"issue":"2","key":"2992_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.118.034645","volume":"138","author":"AD Pradhan","year":"2018","unstructured":"Pradhan AD, Aday AW, Rose LM, Ridker PM. Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy. Circulation. 2018;138(2):141\u20139.","journal-title":"Circulation"},{"issue":"12","key":"2992_CR33","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"1","key":"2992_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12944-025-02627-1","volume":"24","author":"F Kamrani","year":"2025","unstructured":"Kamrani F, Rezaee A, Bigdeloo L, Naseh Mojdehi A, Darroudi S, Hossein Talebkhah M, et al. Concordant and discordant roles of remnant cholesterol and hs-CRP in cardiovascular disease; gender stratified analysis. Lipids Health Dis. 2025;24(1):211.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"2992_CR35","first-page":"125","volume":"27","author":"D El\u00edas-L\u00f3pez","year":"2024","unstructured":"El\u00edas-L\u00f3pez D, Doi T, Nordestgaard BG, Kobylecki CJ. Remnant cholesterol and low-grade inflammation jointly in atherosclerotic cardiovascular disease: implications for clinical trials. Curr Opin Clin Nutr Metab Care. 2024;27(2):125\u201335.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2992_CR36","doi-asserted-by":"publisher","unstructured":"Kraler S, Liberale L, Tirandi A, Moriero M, Wang Y, Farag M et al. The junctional protein associated with coronary artery disease predicts adverse cardiovascular events in patients with acute coronary syndromes at high residual risk. Eur Heart J. 2025:ehaf979. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf979.","DOI":"10.1093\/eurheartj\/ehaf979"},{"issue":"32","key":"2992_CR37","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1093\/eurheartj\/ehaf196","volume":"46","author":"B Bay","year":"2025","unstructured":"Bay B, Tanner R, Gao M, Oliva A, Sartori S, Vogel B, et al. Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention\u2020. Eur Heart J. 2025;46(32):3167\u201377.","journal-title":"Eur Heart J"},{"issue":"47","key":"2992_CR38","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","volume":"42","author":"HN Ginsberg","year":"2021","unstructured":"Ginsberg HN, Packard CJ, Chapman MJ, Bor\u00e9n J, Aguilar-Salinas CA, Averna M, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021;42(47):4791\u2013806.","journal-title":"Eur Heart J"},{"issue":"2","key":"2992_CR39","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.atherosclerosis.2013.02.028","volume":"228","author":"JA van Diepen","year":"2013","unstructured":"van Diepen JA, Berb\u00e9e JF, Havekes LM, Rensen PC. Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis. Atherosclerosis. 2013;228(2):306\u201315.","journal-title":"Atherosclerosis"},{"key":"2992_CR40","doi-asserted-by":"publisher","first-page":"117169","DOI":"10.1016\/j.atherosclerosis.2023.06.075","volume":"379","author":"DC Chan","year":"2023","unstructured":"Chan DC, Kritharides L, Watts GF. The remnant-cholesterol\/CRP nexus: Trouble and strife when the fat hits the fire. Atherosclerosis. 2023;379:117169.","journal-title":"Atherosclerosis"},{"issue":"12","key":"2992_CR41","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJM200003233421202","volume":"342","author":"PM Ridker","year":"2000","unstructured":"Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836\u201343.","journal-title":"N Engl J Med"},{"issue":"5","key":"2992_CR42","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1096\/fasebj.10.5.8621060","volume":"10","author":"MY Farhat","year":"1996","unstructured":"Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J. 1996;10(5):615\u201324.","journal-title":"FASEB J"},{"issue":"9","key":"2992_CR43","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1161\/ATVBAHA.122.318247","volume":"43","author":"DM Conlon","year":"2023","unstructured":"Conlon DM, Welty FK, Reyes-Soffer G, Amengual J. Sex-Specific Differences in Lipoprotein Production and Clearance. Arterioscler Thromb Vasc Biol. 2023;43(9):1617\u201325.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02992-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02992-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02992-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:02:46Z","timestamp":1787151766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02992-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2992"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02992-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics committee of Kailuan General Hospital approved this study, and it followed the principles outlined in the Declaration of Helsinki. Written informed consent was obtained from participants or their legal representatives.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"182"}}